Stroke Trial, Recruiting NCT06541015 Sponsor: University of Texas Southwestern Medical Center Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06541015
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Post-Stroke Group:

  • People who have had a single stroke on one side of the brain that caused weakness in one leg, with the stroke happening more than 6 months ago
  • People who are able to walk as part of their everyday life
  • People aged between 18 and 80

Healthy Comparison Group:

  • People with no history of stroke, cerebral palsy, or injury or surgery to a leg
  • People who are not currently taking any medication that affects the brain or nervous system
  • People who are able to walk as part of their everyday life
  • People aged between 18 and 80

Who may not be able to join:

  • People with serious ongoing medical conditions, such as unhealed pressure sores, active or untreated infections, blood clot disorders, severe joint tightening, brittle bones, bone growths in soft tissue, a broken leg bone, severe lung disease, unstable heart conditions, uncontrolled seizures, or uncontrolled diabetes
  • People with a history of any other neurological condition or brain/nerve injury (for the post-stroke group, this means any condition beyond the single stroke)
  • People who have had a Botox injection in a leg within the last 4 months
  • People with any thinking or memory difficulties that would prevent them from giving informed consent or completing the study tasks
  • People with a history of previous injury or surgery to the hip or knee
  • People with significant swelling in the legs
  • People who have a cardiac pacemaker or any other electrically implanted device
  • People who wear back or spinal braces (such as a TLSO or HALO brace) that would prevent proper fitting of the study equipment
  • People who weigh more than 300 pounds (approximately 136 kilograms)
  • People who are unable to consent for themselves, those under 18, pregnant women, and prisoners
  • People with clinically significant depression, psychiatric disorders, or ongoing drug or substance misuse
  • People currently taking medications known to increase or decrease the activity of the brain's movement-related systems (for example, amphetamines)
  • People who have had a concussion within the last 6 months
  • People who experience unexplained headaches

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yasin Dhaher, Ph.D., University of Texas Southwestern Medical Center

Phone: 214-645-0064

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 June 2019
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reflex Testing; Walking Testing; Adaptation Testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov